Menu
Recruiting NCT07204912

Evaluation of a Neural-Controlled Powered Prosthesis Across Diverse Real-World Tasks

No phase Interventional Transfemoral Amputation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: MIT Powered Leg.
Who it may be relevant to
Registry conditions: Transfemoral Amputation. Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this study is to evaluate the performance and adaptability of a neural-controlled powered knee or ankle prosthesis across diverse real-world mobility tasks. This research aims to assess how compare the sense of embodiment with the device, symmetry, and stability of a person with an lower-extremity amputation walking with a bionic prosthesis and their prescribed prosthesis. Findings from this study will inform future developments in bionic prosthesis design with optimal integration with the human body, with the goal of improving prosthetic integration into daily life.

Interventions

  • Device MIT Powered Leg
    MIT powered knee prosthesis developed by the MIT Biomechatronics Group.

Primary outcome measures

  • Kinematic and Kinetic Measures of Lower-Limb Biomechanics [Time frame: An average of 2 sessions in the span of 1 week]
  • Spatiotemporal Gait Parameters [Time frame: An average of 2 sessions in the span of 1 week]
  • Assessment of Patient Ability to Control each Joint of the Prosthesis [Time frame: An average of 2 sessions in the span of 1 week]

Eligibility criteria

Inclusion criteria

  • Male or Female age 18-70.
  • The patient must have a unilateral transfemoral amputation .
  • The patient must have the ability to ambulate at variable cadence (an expected lower extremity prosthesis functional level of K3 or above).
  • The patient must have adequate socket to support the device.

Exclusion criteria

  • Women who are pregnant.
  • Severe co morbidity, atypical skeletal anatomy, or poor general physical/mental health that, in the opinion of the Investigator, will not allow the subject to be a good study candidate (i.e. other disease processes, mental capacity, substance abuse, shortened life expectancy, vulnerable patient population, BMI >40, etc.).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Single group
Masking
Open label
Primary purpose
Basic science

Study locations

United States · 1 center
  • MIT Media Lab — Cambridge

Identifiers

NCT: NCT07204912 · 2503001589

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗